The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Artificial intelligence and machine learning in drug discovery and development
Open accessAbstract
The current rise of artificial intelligence and machine learning has been significant. It has reduced the human workload improved quality of life significantly. This article describes the use of artificial intelligence and machine learning to augment drug discovery and development to make them more efficient and accurate. In this study, a systematic evaluation of studies was carried out; these were selected based on prior knowledge of the authors and a keyword search in publicly available databases which were filtered based on related context, abstract, methodology, and full text. This body of work supported the roles of machine learning and artificial intelligence in facilitating drug development and discovery processes, making them more cost-effective or altogether eliminating the need for clinical trials, owing to the ability to conduct simulations using these technologies. They also enabled researchers to study different molecules more extensively, without any trials. The results of this paper demonstrate the prevalent application of machine learning and artificial intelligence methods in drug discovery, and indicate a promising future for these technologies; these results should enable researchers, students, and pharmaceutical industry to dive deeper into machine learning and artificial intelligence in a drug discovery and development context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
The benefits and threats of blockchain technology in healthcare: A scoping review
Abu-elezz, I., Hassan, A., Nazeemudeen, A., Househ, M., & Abd-alrazaq, A. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2020.104246 · Cited by 375
Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery
Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00839 · Cited by 278
Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades
Göller, A. H., Kuhnke, L., Montanari, F., Bonin, A., Schneckener, S., ter Laak, A., Wichard, J., Lobell, M., & Hillisch, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.001 · Cited by 215
eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates
Pu, L., Naderi, M., Liu, T., Wu, H.-C., Mukhopadhyay, S., & Brylinski, M. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0282-6 · Cited by 212
Artificial intelligence facilitates drug design in the big data era
Wang, L., Ding, J., Pan, L., Cao, D., Jiang, H., & Ding, X. (2019) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2019.103850 · Cited by 80
Cited by
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,061
The role of firm AI capabilities in generative AI-pair coding
Bughin, J. (2024) · Journal of Decision Systems · doi:10.1080/12460125.2024.2428187 · Cited by 6
Metadata
- Authors
- Patel, V., & Shah, M.
- Venue
- Intelligent Medicine
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 2
- Issue
- 3
- Pages
- 134-140
- ISSN
- 2096-9376 (ISSN-L)
- 2667-1026
- OpenAlex
- W3214371729
- Cited by
- 222
- References
- 9
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Artificial intelligence and machine learning in drug discovery and development. https://app.cochat.ai/papers/10.1016/j.imed.2021.10.001
- The paper
- Patel, V., & Shah, M. (2022). Artificial intelligence and machine learning in drug discovery and development. Intelligent Medicine. https://doi.org/10.1016/j.imed.2021.10.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.